Nyxoah has introduced its Genio neurostimulator, which is intended for obstructive sleep apnoea (OSA) treatment in England, with the first two implants carried out at University College London ...

US-based medical device company Valencia Technologies has received a strategic investment of up to $35m and appointed James ...

Orion system completed a 6-year Early Feasibility Study in 2024 with positive safety and efficacy results. Spin-off is expected to be finalized by or before Q3 2025. Markets are swinging wildly ...